PharmChem, Inc.
PCHM · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $1,580 | $1,522 | $1,575 | $1,542 |
| % Growth | 3.8% | -3.3% | 2.2% | – |
| Cost of Goods Sold | $565 | $550 | $557 | $537 |
| Gross Profit | $1,015 | $972 | $1,017 | $1,005 |
| % Margin | 64.2% | 63.9% | 64.6% | 65.2% |
| R&D Expenses | $2 | $0 | $2 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $658 | $584 | $592 | $347 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $660 | $584 | $593 | $347 |
| Operating Income | $354 | $388 | $424 | $657 |
| % Margin | 22.4% | 25.5% | 26.9% | 42.6% |
| Other Income/Exp. Net | $14 | $14 | $26 | $21 |
| Pre-Tax Income | $368 | $402 | $450 | $678 |
| Tax Expense | $96 | $104 | $98 | $105 |
| Net Income | $272 | $298 | $352 | $572 |
| % Margin | 17.2% | 19.6% | 22.4% | 37.1% |
| EPS | 0.059 | 0.064 | 0.076 | 0.12 |
| % Growth | -8.4% | -15.3% | -36.8% | – |
| EPS Diluted | 0.059 | 0.064 | 0.076 | 0.12 |
| Weighted Avg Shares Out | 4,621 | 4,636 | 4,648 | 4,648 |
| Weighted Avg Shares Out Dil | 4,621 | 4,636 | 4,648 | 4,648 |
| Supplemental Information | – | – | – | – |
| Interest Income | $14 | $18 | $27 | $21 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $368 | $402 | $451 | $678 |
| % Margin | 23.3% | 26.4% | 28.6% | 44% |